European Journal of Biomedical and Pharmaceutical Sciences

ECONOMIC ANALYSIS BETWEEN JAN AUSHADHI AND CONVENTIONAL PHARMACY MEDICINES IN REGARDING ECONOMIC BURDEN ON GERIATRIC POPULATION

Dr. Kodepelli Manisha*, Vodnala Soukya, Thodupunoori Sowmya, Sudagoni Sushma and Thummula Sri Harshini

ABSTRACT

Background: Economic analysis has been identified as one of the comparative analyses of alternative courses of action in terms of both their costs and their consequences for improving the quality of life of patients. Medications include a substantial amount of out-of-pocket expenses in Indian households. To address this issue, the government of India launched the Jan aushadhi scheme to provide cheap generic medicines to patients and there is much discussion regarding the significance of promoting the use of low-cost generic drugs alternatives over brand name drugs. While generic medications have been noted to be comparable to brand-name medications in their ability to treat conditions or concentration of drug reaches its target of action has occurred. The purpose of the study was to do a significantly cost-benefit analysis for patients by giving information about the Jan-Aushadhi scheme to provide low-cost generic medicines to the patients. Conclusion: The results from reviews concluded that shown a very noteworthy difference in prices between branded and generic drugs and also the clinical pharmacist interventions are associated with a reduction of economic burden in the geriatric population to improve clinical outcomes and overcome the misinterpretation of the efficacy of generic drugs and branded drugs.

Keywords: Generic drugs, Branded drugs, economic evaluation, misinterpretation, clinical outcome.